跳到正文
原文
Medical Xpress·· 2026-10-14精选AI 评分69

Frontiers in Immunology:异常自抗体破坏DNA修复机制或与儿童癌症发生相关

Abnormal antibodies that disrupt DNA repair could explain childhood cancer

AI 导读

挪威卑尔根大学科研团队在Frontiers in Immunology发表论文,发现许多儿童癌症患者血清中存在针对自身DNA修复蛋白(如RAD52、NUMA1)的IgG类自抗体。

推荐理由

该观察性研究提示儿童肿瘤患者体内抗DNA修复蛋白自抗体的显著富集,为探索儿童癌症的早期免疫学筛查提供了潜在的理论依据。

正文
childhood cancer
Credit: Unsplash/CC0 Public Domain

A team of scientists in Norway has found evidence for a new mechanism for the development of cancer in children: They seem to produce an unusual amount of aberrant antibodies against the building blocks that make up the DNA repair machinery, a diverse set of hundreds of proteins that identify and correct damage or errors in the genome.

This discovery could open the door to the early screening of small children, in the hope of ultimately preventing them from developing such pediatric cancers in their teenage years.

"We showed that many children with various types of cancer have antibodies against some of their own DNA repair proteins. We also demonstrated that such 'autoantibodies' can enter live cells and bind to—and probably inhibit—the activity of these essential proteins," said corresponding author Dr. Ola Myklebost, an emeritus professor of molecular oncology at the University of Bergen.

The authors published their findings in Frontiers in Immunology.

Why pediatric cancers are different

Pediatric cancers, such as leukemia, myeloma, neuroblastoma and osteosarcoma, differ from adult cancers in their causes, location and type, and response to therapy.

Compared to adults, children have had less time to accumulate cancerous DNA damage through exposure to environmental stressors, lifestyle factors and aging. Pediatric cancers thus tend to carry fewer mutations than adult ones and arise from less mature cells, for example, stem or progenitor cells.

Serguienko, Myklebost and colleagues characterized the proteome—the ensemble of expressed proteins—in tumor and blood samples from 175 adults and children with sarcoma or acute lymphoblastic leukemia, collected between 2014 and 2017 through the NoSarC Norwegian Sarcoma Study, the Norwegian Childhood Cancer Biobank and the Oslo University Hospital Cancer Research Biobank.

They compared these with samples from healthy anonymized people such as blood donors and children participating in the Bergen Growth Study or visiting a clinic in Bergen.

The results showed that compared to young adults and older people, children between 2 and 19 years of age with pediatric cancer had much greater numbers of antibodies of the IgG class against DNA repair proteins circulating in their blood. These autoantibodies mainly targeted RAD52, NUMA1, ALKBH7, APBB1, UNG and MGMT, all key genes closely involved in DNA repair but not significantly mutated in these cancers.

Could these autoantibodies explain why these children had developed cancer? To find out, the scientists looked at selected samples from 59 school-age children who had taken part in the British "Avon Longitudinal Study of Parents and Children" and "Born in Bradford" long-term cohort studies. Half of these children had developed cancer years later (but before the age of 30 years), while the other half had not.

"Although this cohort is small, it was the best we could find internationally," said Myklebost. "Even so, we were able to show that indeed, children who later got cancer (on average six years after blood sampling) were about eight times more likely than their healthy peers to have antibodies to at least one core antigen involved in DNA repair."

Likely role in development of cancer

The authors hypothesized that the targeting of DNA repair proteins by these autoantibodies could provide a phenotype resembling what we see for related proteins with defective hereditary variants that cause a predisposition to cancer.

When the autoantibodies enter a cell or its nucleus, they could bind to and immobilize or directly inhibit the targeted proteins and thus hinder normal DNA repair. Such weakened repair might in turn cause pediatric cancer.

In follow-up experiments, the scientists were able to show that these autoantibodies can enter cells, especially during the phase when cells end their growth and prepare to divide. Inside the cell, they seem to home in on the TIGER organelle, a site where transcription factors and other short-lived but essential proteins are produced and modified.

"[These results] together provide a plausible mechanism for increased cellular damage that could lead to cancer development," concluded the authors.

But what might trigger the production of antibodies against normal DNA repair proteins?

"They could be triggered by infections, by cross-reacting to some microbial proteins or overstimulation of the immune response, or by some imbalance in immune tolerance," hypothesized Myklebost.

The results point to the possibility of screening children to detect any autoimmune predisposition to cancer early, with the hope of preventing their later progression to the disease or detecting it early.

"At present we are investigating the effect of patient antibodies on the repair of induced mutations in cultured cells. Ultimately, we hope to clone white blood cells that secrete such autoantibodies, and test for any cancer-causing effects in mice to definitively prove our hypothesis," said Myklebost.

Publication details

Pathogenic autoantibodies targeting DNA repair proteins are shared by cancer patients and healthy children later diagnosed with cancer, Frontiers in Immunology (2026). DOI: 10.3389/fimmu.2026.1911932

Journal information: Frontiers in Immunology

Who's behind this story?

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Abnormal antibodies that disrupt DNA repair could explain childhood cancer (2026, October 14) retrieved 14 October 2026 from https://medicalxpress.com/news/2026-10-abnormal-antibodies-disrupt-dna-childhood.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com